Appendix B
Workshop Agendas
HEALTH SYSTEMS WORKSHOP
August 5–7, 2015
La Palm Royal Beach Hotel
Accra, Ghana
Wednesday, August 5, 2015 (Day 1)
8:30–8:50 am |
Welcome |
Michael Myers, Managing Director, The Rockefeller Foundation; Co-Chair, Workshop Planning Committee |
|
Francis Omaswa, Executive Director of the African Centre for Global Health and Social Transformation; Co-Chair, Workshop Planning Committee |
|
Opening Remarks |
|
Aba Bentil Andam, Vice President, Ghana Academy of Arts and Sciences Representative |
|
8:50–9:10 |
Overview of the National Academy of Medicine’s Global Health Risk Framework Initiative |
Patrick Kelley, Director, Board on Global Health, Institute of Medicine (IOM), USA |
Session I: Opening Plenary: Lessons from a Historical Perspective
Session Moderator: Gabriel Leung, Dean, Li Ka Shing Faculty of Medicine,
The University of Hong Kong; Workshop Planning Committee
9:10–10:30 |
Case Study Panel Presentation |
Rob Fowler, Physician, University of Toronto, Canada |
|
Jane Ruth Aceng, Director General of Health Services, Ministry of Health, Kampala, Uganda |
|
Trish M. Perl, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, USA |
|
10:30–11:00 |
Break |
Session II: Building Health Systems Resilience
Session Moderator: Francis Omaswa
11:00–11:45 |
Building Sustainable Health Resilience: A Systems Approach |
Michael Myers |
|
11:45 am–12:30 pm |
Discussion with Attendees and Case Study Panelists |
12:30–1:30 |
Lunch |
Session III: Focus Area Discussions
1:30–3:30 |
Breakout Discussions by Focus Area |
Focus Area 1: Disease Surveillance Systems |
|
Facilitators: David Fitter, Epidemiologist, Emergency Response and Recovery Branch, U.S. Centers for Disease Control and Prevention (CDC) |
|
Oyewale Tomori, President, Nigerian Academy of Science; Workshop Planning Committee |
|
Focus Area 2: Local and Regional Workforce Capacity |
|
Facilitator: Stella Anyangwe, Honorary Professor in Epidemiology, School of Health Systems and Public Health, University of Pretoria |
|
Patrick M. Nguku, African Field Epidemiology Network, Nigeria Field Epidemiology and Laboratory Training Program |
|
Abdulsalami Nasidi, Director General, Nigerian Centre for Disease Control |
|
Jim Campbell, Director, Health Workforce, World Health Organization (WHO) Executive Director, Global Health Workforce Alliance |
|
Focus Area 3: Health Care and Public Health Integration |
|
Facilitator: P. Gregg Greenough, Research Director, Harvard Humanitarian Initiative, Harvard School of Public Health |
|
Koku Awoonor-Williams, Regional Director of Health Service for the Upper East Region of Ghana |
|
Focus Area 4: Community Engagement |
|
Facilitator: Ben Adeiza Adinoyi, Africa Zone Health and Care Coordinator, International Federation of Red Cross and Red Crescent Societies; Workshop Planning Committee |
|
Mosoka Fallah, Co-Principal Investigator: Ebola Natural History Study; US-Liberian Research Partnership/NIAID, Liberia |
|
Janet Nakuti, Senior Program Officer, Monitoring and Documentation, Raising Voices, Kampala Uganda |
|
3:30–4:00 |
Break |
Session IV: Plenary: Report Out
Session Moderator: Michael Myers
4:00–4:45 |
Report Out by Facilitators |
4:45–5:30 |
Large Group Discussion |
5:30 |
Adjourn |
5:30–7:00 |
Reception |
Thursday, August 6, 2015 (Day 2)
8:30–8:45 am |
Welcome |
Michael Myers |
|
Francis Omaswa |
|
Opening Remarks |
|
Delanyo Dovlo, Director, Health Systems and Services Cluster, WHO Africa Regional Office |
Session V: Cross-Sector Engagement in Building Systems to Support Health
Session Moderator: Ann Marie Kimball, Senior Consulting Fellow,
Royal Institute of Foreign Affairs, Chatham House; Workshop Planning Committee
8:45–10:15 |
Panel Discussion: Cross-Sector Engagement |
Public Health |
|
Peter Lamptey, Distinguished Scientist and President Emeritus, FHI360 |
|
Mental Health |
|
Inge Petersen, Professor of Psychology, University of KwaZulu-Natal, South Africa |
|
Health Care |
|
Kumanan Rasanathan, Senior Health Specialist, United Nations Children’s Fund (UNICEF) |
|
Business/Private Sector |
|
Graham Davidson, Managing Director, Simandou Project, Guinea, Rio Tinto |
|
Nana Yaa Afriyie Ofori-Koree, Foundation and Sustainability Manager, Vodafone Ghana Foundation |
|
Nongovernmental Organization (NGO)/Civil Society |
|
Saran Kaba Jones, Founder and Executive Director, FACEAfrica, Liberia |
|
10:15–10:45 |
Break |
10:45–11:45 |
Discussion with Attendees: Reaction to Panel Discussion |
11:45 am–12:45 pm |
Lunch |
Session VI: Focus Area Discussions
12:45–3:15 |
Breakout Discussions by Focus Area |
Focus Area 1: Health Information Systems |
|
Facilitator: Paul Biondich, Research Scientist, Regenstrief Institute, Inc. |
|
Kate Wilson, Director of Digital Health Solutions, PATH, USA |
|
Focus Area 2: Incorporating Global Reserve Teams on the Ground |
|
Facilitator: Jim Campbell |
|
Ian Norton, Foreign Medical Teams Working Group, WHO, Australia |
|
Lewis Rubinson, Director, Critical Care Resuscitation Unit, University of Maryland, USA |
|
Focus Area 3: Health Care Delivery and Supply Chain |
|
Facilitator: David Sarley, Senior Program Officer, The Bill & Melinda Gates Foundation |
|
Lloyd Matowe, Director, Pharmaceutical Systems Africa |
|
Raj Panjabi, CEO of Liberian NGO Last Mile Health |
|
Focus Area 4: Leadership and Management |
|
Facilitator: Dan Hanfling, Contributing Scholar, University of Pittsburgh Medical Center, USA |
|
Ali Ardalan, Associate Professor and Chair, Disaster and Emergency Health Academy, Tehran University of Medical Sciences, Iran |
|
3:15–3:30 |
Break |
Session VII: Plenary: Report Out
Session Moderator: Francis Omaswa
3:30–4:30 |
Report Out by Facilitators |
4:30–5:15 |
Large Group Discussion |
5:15 |
Adjourn |
Friday, August 7, 2015 (Day 3)
9:00–9:15 am |
Welcome |
Michael Myers |
|
Francis Omaswa |
Session VIII: Synthesizing Components to Build Resilient Health Systems
Session Moderators: Michael Myers
Francis Omaswa
9:15–9:45 |
Building Integrated, Sustainable, and Resilient Health Systems—Reflections from the Workshop Planning Committee |
Planning Committee Panelists | |
David Fitter |
|
Ann-Marie Kimball |
|
Ben Adeiza Adinoyi |
|
Aba Bentil Andam |
|
9:45–10:15 |
Discussion with Attendees |
10:15–10:30 |
Break |
10:30–11:30 |
Building Integrated, Sustainable, and Resilient Health Systems—A Reaction Panel |
Peter Lamptey |
|
Raphael Frankfurter, Executive Director, Wellbody Alliance |
|
Delanyo Dovlo |
|
Daniel López-Acuña, Former Director for Recovery and Transition, Cluster of Health Action in Crisis, WHO |
|
Marie Claire Tchecola, Nurse, Donka Hospital, Conakry, Guinea (Translation by Pascale Krumm, Health Communications Office, CDC) |
|
11:30 am–12:00 pm |
Wrap Up and Discussion with Attendees |
12:00 |
Closing Remarks |
Patrick Kelley |
|
Michael Myers |
|
Francis Omaswa |
|
12:15 |
Workshop Adjourned |
• • •
RESEARCH AND DEVELOPMENT OF MEDICAL PRODUCTS WORKSHOP
August 19–21, 2015
Cheung Kung Hai Conference Centre
Hong Kong
Wednesday, August 19, 2015 (Day 1)
8:40 am |
Welcome |
Gabriel Leung, Li Ka Shing Faculty of Medicine, The University of Hong Kong |
|
Victor Dzau, National Academy of Medicine |
|
Keynote Lecture |
Margaret Chan, WHO |
Session I: Incentives and Development Models
Moderator: Tachi Yamada, Frazier Life Sciences
Objectives:
- Review existing incentives, business models, and partnership approaches that support the research and development of medical products for emerging infectious diseases.
- Identify shortcomings in existing regulatory and financial incentives, and highlight promising ideas for improvements that can help advance the development of medical products for emerging infectious diseases.
- Discuss challenges to building and sustaining more effective business models and public private partnerships; explore promising approaches and identify key attributes of a well working collaborative approach.
9:30 |
Segment A: Existing and Promising Incentives |
Keynote Lecture |
|
BT Slingsby, Global Health Innovative Technologies Fund |
|
Panel Discussion |
|
Lynn Marks, GlaxoSmithKline |
|
Rajeev Venkayya, Takeda Pharmaceuticals |
|
Kevin Outterson, Boston University |
|
10:50 |
Break |
11:00 |
Segment B: Sustainable and Effective Business Models and Public–Private Partnerships |
Keynote Lectures |
|
David Reddy, Medicines for Malaria Venture |
|
Krishna Ella, Bharat Biotech International Limited |
|
Panel Discussion |
|
Mel Spigelman, TB Alliance |
|
Graeme Bilbe, Drugs for Neglected Diseases Initiative |
|
Peter Dull, The Bill & Melinda Gates Foundation |
|
12:30 pm |
Lunch |
Session 2: Science and Regulatory Convergence and Capacity
Moderator: Maria Freire, Foundation for the National Institutes of Health
Objectives:
- Review and characterize the needs and gaps in current scientific tools, technologies, and capacities to develop and evaluate products.
- Highlight promising common platforms to enable nimble and rapid development and evaluation of products.
- Discuss whether and how discordant regulatory specifications hinder efficient development and evaluation of medical products, and possible approaches for convergence.
- Characterize the critical needs of country regulatory authorities in times of public health emergency and discuss potential strategies regulators and international organizations can take to help address these needs.
- Discuss potential strategies for encouraging the sharing of knowledge, clinical, and clinical trial data to speed clinical assessment of investigational products for emerging infectious disease.
1:30 |
Segment A: State of the Science |
Keynote Lectures |
|
Michael Pfleiderer, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines |
|
Trevor Mundel, The Bill & Melinda Gates Foundation |
|
Panel Discussion |
|
Margaret Hamburg, National Academy of Medicine |
|
Rudi Pauwels, BioCartis NV |
|
Charles Goldstein, Becton Dickinson |
|
Adel Mahmoud, Princeton University |
|
Craig E. Colton, 3M Personal Safety Division |
|
3:00 |
Segment B: Sharing of Data and Reagents, Intellectual Property and Liability |
Keynote Lecture |
|
Anthony So, Duke University |
|
Panel Discussion |
|
Michelle Mulder, South African Medical Research Council |
|
Lynn Marks, GlaxoSmithKline |
|
Reid Adler, Practical Innovation Strategy |
|
4:20 |
Break |
4:30 |
Segment C: Global Regulatory Convergence and Capacity |
Keynote Lectures |
|
Margaret Hamburg |
|
Hans-Georg Eichler, European Medicines Agency |
|
Panel Discussion |
|
Raymond Chua, Singapore Health Sciences Authority |
|
Mike Ward, WHO |
|
6:00 |
Adjourn |
Thursday, August 20, 2015 (Day 2)
Session 3: Clinical Assessment
Moderator: Maria Freire
Objectives:
- Examine barriers to the clinical assessment of the safety and efficacy of investigational medical products in communities experiencing a public health emergency from an emerging infectious disease.
- Discuss a framework for determining when investigational products should be subjected to controlled clinical assessment and when they should be used more broadly under other mechanisms.
- Describe responsible and adaptive clinical trial designs that could be developed for use in times of public health emergencies and discuss ethical considerations associated with the possible options.
- Consider ethical and methodological standards that may be used to determine optimal trial designs for assessing the readiness of investigational medical products prior to broader deployment during public health emergency.
- Highlight strategies for engaging communities during times of public health emergency to determine how and when to undertake controlled clinical assessment and, where trials are used, to facilitate rapid and fair enrollment in trials for investigational products.
9:00 am |
Segment A: Ethical Principles and Methodological Framework for Clinical Trial Designs |
Keynote Lectures |
|
Andre Kalil, University of Nebraska Medical Center |
|
Fred Binka, University of Health and Allied Sciences, Ghana |
|
Panel Discussion |
|
Luciana Borio, U.S. Food and Drug Administration (FDA) (via video conference) |
|
Paul Stoffels, Johnson & Johnson |
|
Mike Levine, University of Maryland School of Medicine |
|
Peter Kilmarx, Fogarty International Center, National Institutes of Health |
|
Rob Califf, U.S. FDA (via video conference) |
|
11:00 |
Break |
11:10 |
Segment B: Practical Considerations and Community Engagement |
Keynote Lecture |
|
Samba Sow, Center for Vaccine Development, Mali |
|
Panel Discussion |
|
Joan Awunyo-Akaba, Future Generations International, Ghana |
|
Beth Bell, U.S. CDC |
|
Fred Binka |
|
12:30 pm |
Lunch |
Session 4: Manufacturing, Stockpiling and Deployment
Moderator: Tachi Yamada
Objectives:
- Characterize the needs and gaps in current manufacturing, stockpiling, and supply chain mechanisms for medical product development and deployment during public health emergencies.
- Highlight promising approaches for delivery and deployment of products that are manufactured outside of an affected region during public health emergencies.
- Discuss the ethical considerations of different manufacturing approaches and deployment capabilities.
1:30 |
Segment A: Manufacturing and Stockpiling |
Keynote Lecture |
|
Rajeev Venkayya, Takeda Pharmaceuticals |
|
Discussion Panel |
|
Krishna Ella, Bharat Biotech International Limited |
|
Shanelle Hall, UNICEF |
|
2:50 |
Break |
3:00 |
Segment B: Supply Chain Mechanisms and Deployment |
Keynote Lecture |
|
David Ripin, Clinton Health Access Initiative (CHAI) |
|
Discussion Panel |
|
Shanelle Hall |
|
Rajeev Venkayya |
|
4:00 |
Adjourn |
Friday, August 21, 2015 (Day 3)
Session 5: Top Priorities for Facilitating Medical Product Research and Development
Moderators: Maria Freire
Tachi Yamada
Objectives:
- Examine the ethical and practical considerations for setting priorities to facilitate medical product research, development, and availability.
- Discuss potential strategies for developing a structure and process to select priorities for medical product research, development, and availability.
- Discuss potential strategies for encouraging collaboration and information sharing among private companies to speed research and development for top priorities.
- Explore how to align regulatory considerations, development milestones, and financing models for designated top priorities.
9:00 am |
Summary Lecture |
Tachi Yamada |
|
Panel Discussion |
|
Robin Robinson, Biomedical Advanced Research and Development Authority, U.S. Department of Health and Human Services (via video conference) |
|
Peter Kilmarx |
|
Paul Stoffels |
|
Glenda Gray, South African Medical Research Council |
|
11:20 |
Closing Remarks |
Ceci Mundaca-Shah, National Academies of Sciences, Engineering, and Medicine |
|
11:30 |
Adjourn |
• • •
PANDEMIC FINANCING WORKSHOP
August 27–28, 2015
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington DC
Thursday, August 27, 2015 (Day 1)
8:00–8:30 am |
Breakfast available |
Session I: Welcome and Overview
Objective: To introduce the agenda and give an overview of the workshop’s key themes.
8:30–9:00 |
Welcome and Introductions |
Prashant Yadav, Vice President and Senior Research Fellow, William Davidson Institute, University of Michigan |
|
Victor Dzau, President, National Academy of Medicine |
|
9:00–10:30 |
International Cooperative Action on Pandemics |
Moderator: Olga Jonas, Economic Adviser and Coordinator, Operational Response to Avian and Pandemic Influenzas, World Bank | |
Gordon Woo, Catastrophist, Risk Management Solutions |
|
Jordan Tappero, Director Division of Global Health Protection, U.S. CDC |
|
Eduardo González Pier, Vice Minister Integration and Development, Ministry of Health, Mexico |
|
Aron Betru, CEO, Financing for Development |
|
10:30–10:45 |
Break |
Session II: Marshaling Funding for Preparedness and Response
Objective: To discuss different options for making funding available in low- and middle-income
countries during a pandemic and the circumstances that favor certain options over others.
10:45–11:45 |
Pandemic Emergency Funds: The WHO Contingency Fund, the World Bank, and IMF Financing Facilities |
Moderator: Peter Sands, Former Group CEO, Standard Chartered PLC | |
Katherine DeLand, Chief of Staff, Ebola Response, WHO |
|
Chris Lane, Division Chief, Low-Income Countries Strategy, Policy and Review, IMF |
|
Priya Basu, Manager, Development Finance, The World Bank Group |
|
11:45 am–1:15 pm |
Adapting Insurance Products for Pandemic Risk |
Moderator: Panos Varangis, Global Lead, Agricultural Finance and Disaster Risk Finance, Finance and Markets Global Practice, IFC |
|
Olivier Mahul, Program Manager, Disaster Risk Financing & Insurance, World Bank |
|
Nikhil da Victoria Lobo, Head, Global Partnerships, Americas, Swiss Re |
|
Simon Young, GeoSY Ltd. |
|
José Ángel Villalobos, Senior Insurance Specialist, World Bank |
|
Gunther Kraut, Financial Solutions Life, Munich Re (by video) |
|
1:15–2:15 |
Lunch |
2:15–3:45 |
Innovative Financing for Preparedness and Response |
Moderator: Juan Costain, Lead Financial Specialist, World Bank |
|
Paolo Sison, Director Innovative Finance, Gavi, The Vaccine Alliance |
|
Christopher Egerton-Warburton, Partner, Lion’s Head Global Partners |
|
Lelio Marmora, Executive Director, UNITAID |
|
Adam Bornstein, Specialist Innovative Health Financing, The Global Fund |
|
3:45–4:00 |
Break |
Session III: Identifying Triggers and Modelling Risk
Objective: To discuss a verifiable trigger for payout and a suitable group to adjudicate triggers, to understand what models can tell us about pandemic risk.
4:00–5:30 |
Modelling and Triggers for Payout |
Moderator: Prashant Yadav |
|
Nathan Wolfe, CEO, Metabiota |
|
Martin Meltzer, Lead, Health Economics and Modeling Unit, U.S. CDC |
|
Gordon Woo |
|
Nita Madhav, Principal Scientist, Research and Modelling, AIR Worldwide |
|
5:30 |
Adjourn |
All participants and guests are invited to a reception in the Great Hall immediately following the meeting.
6:30 |
Dinner in the National Academy of Sciences Building for speakers, moderators, and invited guests |
Friday, August 28, 2015 (Day 2)
8:30–9:00 am |
Breakfast available |
9:00–9:15 |
Welcome and Overview |
Prashant Yadav |
Session IV: Management and Administration of Funds
Objective: To understand the constraints on donors and discuss how financial tools can be designed to encourage risk sharing and crowding in; to discuss the administrative burden emergency payments place recipient country governments.
9:15–10:45 |
Financing Challenges In-Country |
Moderator: Peter Sands |
|
Tendai Biti, Former Minister of Finance, Zimbabwe |
|
Gordon Liu, Yangtze River Scholar, Professor of Economics, National School of Development, Peking University |
|
Victor Bampoe, Deputy Minister of Health, Ghana |
|
James Kollie, Deputy Minister for Fiscal Affairs, Ministry of Finance and Development Planning, Liberia |
|
10:45–11:00 |
Break |
11:00 am–12:30 pm |
Donor Considerations and Crowding-In |
Moderator: Trish Stroman, Partner and Managing Director, BCG |
|
Tore Godal, Special Advisor, Office of the Prime Minister, Norway |
|
Jennifer Adams, Deputy Assistant Administrator, Bureau for Global Health, USAID |
|
Gargee Ghosh, Director Development Policy and Finance, The Bill & Melinda Gates Foundation |
|
Erin Hohlfelder, Policy Director Global Health, ONE Campaign |
|
12:30–1:30 |
Lunch |
Session V: Financing Preparedness and Giving Incentives
Objective: To explain how financial incentives can be used to encourage preparedness and health systems development.
1:30–3:00 |
The Investment Case for Preparedness and the Role of the Private Sector |
Moderator: Eduardo González Pier, Vice Minister Integration and Development, Ministry of Health, Mexico |
Staci Warden, Executive Director Center for Financial Markets, Milken Institute Trish Stroman |
|
Daniel Hanna, Managing Director, Head of Public Sector and Development Organisations: Africa, Americas and Europe, Standard Chartered Bank |
|
David Crush, Manager, IFC |
|
3:00–3:15 |
Break |
3:15–4:45 |
Incentives and Preparedness |
Moderator: Milan Brahmbhatt, Senior Fellow, World Resources Institute |
|
Richard Gregory, Senior Policy Advisor, Global Health Security, DfID |
|
David Nabarro, Secretary General’s Special Envoy on Ebola, UN (by video) |
|
George Gao, Deputy Director-General, China CDC |
|
Hans Troedsson, Assistant Director General for General Management, WHO |
|
4:45–5:00 |
Closing Remarks |
5:00 |
Adjourn |
• • •
GOVERNANCE FOR GLOBAL HEALTH WORKSHOP
September 1–2, 2015
Wellcome Trust—Gibbs Building
London, United Kingdom
Tuesday, September 1, 2015 (Day 1)
8:00–8:30 am |
Registration and Continental Breakfast |
8:30–8:40 |
Welcome Jeremy Farrar, Director, Wellcome Trust |
David Relman, Chair of the Forum on Microbial Threats, IOM; Professor of Microbiology and Immunology, Stanford University |
|
8:40–8:55 |
Overview of the Global Health Risk Framework Initiative |
Patrick Kelley, Director, Board on Global Health, IOM |
|
8:55–9:00 |
Keynote Introduction |
David Relman |
|
9:00–9:30 |
Keynote Remarks: Governance for Global Health—Engaging Intergovernmental Organizations to Achieve Collection Action |
Keizo Takemi, Member of Japanese Parliament |
Session I: Definition of Governance for Global Health and Lessons Learned from Outbreaks of the Past
Session Moderator: Ximena Aguilera, Director, Center of Epidemiology and Public Health Policies, Universidad del Desarrollo, Chile
Objectives:
- Illuminate key elements of “good” governance for global health.
- Examine compliance enhancing mechanisms to drive good governance and implementation of existing international norms.
- Synthesize lessons learned from recent infectious disease outbreaks and opportunities to strengthen governance for global health.
- Identify ways in which International Health Regulations (IHR) can be modified to achieve its intended purpose.
9:30–10:10 |
Part 1: Elements of Good Governance for Global Health |
Presentations |
|
David Fidler, Professor of Law, Indiana University |
|
Alejandro Thiermann, President, Terrestirial Animal Health Code Commission, World Organisation for Animal Health (OIE) |
|
10:10–10:30 |
Discussion |
10:30–10:45 |
Break |
10:45–11:45 |
Part 2: Lessons Learned from Outbreaks of the Past |
Case Study Panel |
|
David Heymann, Head/Chair, Public Health England/Chatham House |
|
Harvey Fineberg, President, Moore Foundation |
|
Joanne Liu, President, Médecins Sans Frontières |
|
11:45 am–12:45 pm |
Discussion |
12:45–1:30 |
Lunch |
Session II: Challenges in Governance for Global Health for Fragile States
Session Moderator: Oyewale Tomori, President, Nigerian Academy of Science
Objectives:
- Compare and contrast different governance approaches for fragile health systems vs. other areas and identify where new approaches are relevant.
- Identify how to measure and define success of governance for global health for areas with weak political systems and economies.
1:30–2:10 |
Presentations |
Paul Wise, Professor of Pediatrics and Health Policy, Stanford University School of Medicine; Senior Fellow, Freeman-Spogli Institute for International Studies, Stanford University |
|
Mark Heywood, Executive Director, Section27 (South Africa) |
2:10–2:40 |
Discussion |
Session III: Challenges in Current Design of Global Health Governance
Session Moderator: Margaret A. Hamburg, Former Commissioner, U.S. FDA
Objectives:
- Highlight ways WHO and member states can be better equipped to address global outbreaks.
- Discuss recent proposals made to enhance global preparedness and response.
- Identify how global security initiatives and frameworks can work together to boost preparedness and response.
2:40–4:30 |
Presentations |
Charles Clift, Senior Consulting Fellow, Center on Global Health Security, Chatham House |
|
Margaret Chan, Director General, WHO |
|
Colin McIff, Senior Health Attaché, U.S. Mission, Geneva |
|
Dame Barbara Stocking, President, Murray Edwards College |
|
4:30–4:50 |
Break |
4:50–6:00 |
Panel Discussion |
6:00–6:15 |
Concluding Remarks |
David Relman |
|
6:15 |
Adjourn |
Wednesday, September 2, 2015 (Day 2)
8:30–9:00 am |
Registration and Continental Breakfast |
9:00–9:15 |
Summary of Day One |
David Relman |
Session IV: Models of Governance for Global Health
Moderator: Larry Gostin, University Professor of Global Health Law, Georgetown University
Objectives:
- Illuminate goals of governance systems considering domains from the international, national, regional, and local levels.
- Compare and contrast four potential models of governance for global health, including key features of organizational structure, funding, legitimacy, authority, and accountability.
- Identify a broad array of stakeholders and effective methods for integrating and leveraging partner engagements for strong governance for global health.
9:15–10:05 |
Part 1: Systems for Governance: How Should They Fit Together? |
Presentations |
|
Claude de Ville de Goyet, Consultant to UN and Former WHO/Pan American Health Organization Emergency Preparedness Director |
|
Ron St. John, WHO Consultant |
|
10:05–10:20 |
Break |
10:20–11:10 |
Presentations |
Ben Anyene, Chairman, Health Reform Foundation of Nigeria |
|
Rebecca Marmot, Vice President, Global Partnerships, Unilever |
|
11:10 am–12:10 pm |
Panel Discussion |
12:10–1:00 |
Lunch |
1:00 |
Part 2: Laying Out Some Governance Options: The Work of Concurrent Panels and Debate |
1:00–1:40 |
Insights from Concurrent Initiatives |
Peter Piot, Director, London School of Hygiene & Tropical Medicine |
|
Joy Phumaphi, Executive Secretary of African Leaders Malaria Alliance, Member of UN High-Level Panel on Global Response to Health Crises |
|
1:40–1:50 |
The Debate: Introduction |
Moderator: Larry Gostin | |
1:50–2:10 |
Model 1: WHO Status Quo |
Charles Clift |
|
2:10–2:30 |
Model 2: “WHO Plus” |
WHO with an attached center for humanitarian and outbreak management under the line authority of the WHO Director-General and with strategic, operational, and tactical roles. It combines both strategic and operational missions within the WHO-Geneva culture. Ilona Kickbusch, Director, Global Health Programme, Graduate Institute of Geneva | |
2:30–2:50 |
Model 3: The Executive Agency Model |
WHO as the host for a center for humanitarian and outbreak management operating under the authorities of the UN Secretary-General and executing strategic, operational, and tactical roles. (This taps the expertise of WHO but draws from a higher level of authority for command and control and political support.) It would insulate the Center from the WHO culture and the politics of the World Health Assembly but derive vast technical benefits.
Yasushi Katsuma, Dean, Graduate School of Asia-Pacific Studies, Waseda University |
2:50–3:10 |
Model 4: The Model of the UN Office for the Coordination of Humanitarian Assistance |
A separate agency. | |
Daniel López-Acuña |
|
3:10–4:00 |
Panel and General Discussion |
Moderator: Harvey Fineberg | |
Featured Reactors |
|
Kenji Shibuya, Professor and Chair of Global Health Policy, University of Tokyo |
|
Ann Marie Kimball, Senior Consulting Fellow, Chatham House |
|
4:00–4:15 |
Break |
Session V: Other Considerations in Governance for Global Health
Moderator: Chris Elias, President, Global Development, The Bill & Melinda Gates Foundation
Objectives:
- Synthesize best practices for translating research and lessons learned into actions for governance for global health.
- Identify financing mechanisms that help mobilize and maintain good governance and steer policy directions.
4:15–5:15 |
Panel Discussion |
Tim Evans, Senior Director, Health, Nutrition and Population Global Practice, World Bank |
|
Jeremy Farrar |
|
Daniel López-Acuña |
|
5:15–5:45 |
Open Discussion |
5:45–6:00 |
Concluding Remarks |
Eileen Choffnes, Scholar, Board on Global Health, IOM |
|
Ceci Mundaca-Shah, Senior Program Officer, Board on Global Health, IOM |
|
David Relman |
|
6:00 |
Adjourn |
This page intentionally left blank.